世界のリヴァロクサバン市場2018

QYResearchが発行した調査報告書(QYR80711193)
◆英語タイトル:Global Rivaroxaban Sales Market Report 2018
◆商品コード:QYR80711193
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年6月18日
◆ページ数:101
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥864,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、リヴァロクサバンの世界市場について調査・分析し、リヴァロクサバンのメーカー別販売量、市場シェア分析、種類別販売分析(2.5 mg、10 mg、15 mg、20 mg)、用途別販売分析(急性冠動脈症候群(ACS)、静脈血栓塞栓症(VTE))、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、リヴァロクサバン産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・リヴァロクサバン市場概要
・リヴァロクサバンのメーカー別販売量・メーカー別シェア
・リヴァロクサバンの世界市場:種類別販売量(2.5 mg、10 mg、15 mg、20 mg)
・リヴァロクサバンの世界市場:用途別販売量(急性冠動脈症候群(ACS)、静脈血栓塞栓症(VTE))
・リヴァロクサバンの世界市場:地域別販売量・市場シェア
・リヴァロクサバンの米国市場規模
・リヴァロクサバンの中国市場規模
・リヴァロクサバンの欧州市場規模
・リヴァロクサバンの日本市場規模
・リヴァロクサバンの東南アジア市場規模
・リヴァロクサバンのインド市場規模
・リヴァロクサバンのメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・リヴァロクサバンのコスト分析・価格動向
・リヴァロクサバンの産業チェーン(サプライチェーン分析)
・リヴァロクサバンのマーケティング戦略・販売チャネル、流通業者
・リヴァロクサバン市場への影響要因分析
・リヴァロクサバンの世界市場予測
・リヴァロクサバンの米国市場予測
・リヴァロクサバンの中国市場予測
・リヴァロクサバンの欧州市場予測
・リヴァロクサバンの日本市場予測
・リヴァロクサバンの東南アジア市場予測
・リヴァロクサバンのインド市場予測
・リヴァロクサバンの種類別世界市場予測(2.5 mg、10 mg、15 mg、20 mg)
・リヴァロクサバンの用途別世界市場予測(急性冠動脈症候群(ACS)、静脈血栓塞栓症(VTE))
...
【レポートの概要】

This report studies the global Rivaroxaban market status and forecast, categorizes the global Rivaroxaban market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.
Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.
The global Rivaroxaban market is valued at 5860 million US$ in 2017 and will reach 11000 million US$ by the end of 2025, growing at a CAGR of 8.2% during 2018-2025.

The major players covered in this report
Bayer
J&J

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
2.5 mg
10 mg
15 mg
20 mg
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)

The study objectives of this report are:
To analyze and study the global Rivaroxaban sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Rivaroxaban players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Rivaroxaban are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Rivaroxaban Manufacturers
Rivaroxaban Distributors/Traders/Wholesalers
Rivaroxaban Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Rivaroxaban market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Rivaroxaban Sales Market Report 2018
1 Rivaroxaban Market Overview
1.1 Product Overview and Scope of Rivaroxaban
1.2 Classification of Rivaroxaban by Product Category
1.2.1 Global Rivaroxaban Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Rivaroxaban Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 2.5 mg
1.2.4 10 mg
1.2.5 15 mg
1.2.6 20 mg
1.3 Global Rivaroxaban Market by Application/End Users
1.3.1 Global Rivaroxaban Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Acute Coronary Syndrome (ACS)
1.3.2 Venous Thromboembolism (VTE)
1.4 Global Rivaroxaban Market by Region
1.4.1 Global Rivaroxaban Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Rivaroxaban Status and Prospect (2013-2025)
1.4.3 Europe Rivaroxaban Status and Prospect (2013-2025)
1.4.4 China Rivaroxaban Status and Prospect (2013-2025)
1.4.5 Japan Rivaroxaban Status and Prospect (2013-2025)
1.4.6 Southeast Asia Rivaroxaban Status and Prospect (2013-2025)
1.4.7 India Rivaroxaban Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Rivaroxaban (2013-2025)
1.5.1 Global Rivaroxaban Sales and Growth Rate (2013-2025)
1.5.2 Global Rivaroxaban Revenue and Growth Rate (2013-2025)

2 Global Rivaroxaban Competition by Players/Suppliers, Type and Application
2.1 Global Rivaroxaban Market Competition by Players/Suppliers
2.1.1 Global Rivaroxaban Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Rivaroxaban Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Rivaroxaban (Volume and Value) by Type
2.2.1 Global Rivaroxaban Sales and Market Share by Type (2013-2018)
2.2.2 Global Rivaroxaban Revenue and Market Share by Type (2013-2018)
2.3 Global Rivaroxaban (Volume and Value) by Region
2.3.1 Global Rivaroxaban Sales and Market Share by Region (2013-2018)
2.3.2 Global Rivaroxaban Revenue and Market Share by Region (2013-2018)
2.4 Global Rivaroxaban (Volume) by Application

3 United States Rivaroxaban (Volume, Value and Sales Price)
3.1 United States Rivaroxaban Sales and Value (2013-2018)
3.1.1 United States Rivaroxaban Sales and Growth Rate (2013-2018)
3.1.2 United States Rivaroxaban Revenue and Growth Rate (2013-2018)
3.1.3 United States Rivaroxaban Sales Price Trend (2013-2018)
3.2 United States Rivaroxaban Sales Volume and Market Share by Players (2013-2018)
3.3 United States Rivaroxaban Sales Volume and Market Share by Type (2013-2018)
3.4 United States Rivaroxaban Sales Volume and Market Share by Application (2013-2018)

4 Europe Rivaroxaban (Volume, Value and Sales Price)
4.1 Europe Rivaroxaban Sales and Value (2013-2018)
4.1.1 Europe Rivaroxaban Sales and Growth Rate (2013-2018)
4.1.2 Europe Rivaroxaban Revenue and Growth Rate (2013-2018)
4.1.3 Europe Rivaroxaban Sales Price Trend (2013-2018)
4.2 Europe Rivaroxaban Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Rivaroxaban Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Rivaroxaban Sales Volume and Market Share by Application (2013-2018)

5 China Rivaroxaban (Volume, Value and Sales Price)
5.1 China Rivaroxaban Sales and Value (2013-2018)
5.1.1 China Rivaroxaban Sales and Growth Rate (2013-2018)
5.1.2 China Rivaroxaban Revenue and Growth Rate (2013-2018)
5.1.3 China Rivaroxaban Sales Price Trend (2013-2018)
5.2 China Rivaroxaban Sales Volume and Market Share by Players (2013-2018)
5.3 China Rivaroxaban Sales Volume and Market Share by Type (2013-2018)
5.4 China Rivaroxaban Sales Volume and Market Share by Application (2013-2018)

6 Japan Rivaroxaban (Volume, Value and Sales Price)
6.1 Japan Rivaroxaban Sales and Value (2013-2018)
6.1.1 Japan Rivaroxaban Sales and Growth Rate (2013-2018)
6.1.2 Japan Rivaroxaban Revenue and Growth Rate (2013-2018)
6.1.3 Japan Rivaroxaban Sales Price Trend (2013-2018)
6.2 Japan Rivaroxaban Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Rivaroxaban Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Rivaroxaban Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Rivaroxaban (Volume, Value and Sales Price)
7.1 Southeast Asia Rivaroxaban Sales and Value (2013-2018)
7.1.1 Southeast Asia Rivaroxaban Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Rivaroxaban Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Rivaroxaban Sales Price Trend (2013-2018)
7.2 Southeast Asia Rivaroxaban Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Rivaroxaban Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Rivaroxaban Sales Volume and Market Share by Application (2013-2018)

8 India Rivaroxaban (Volume, Value and Sales Price)
8.1 India Rivaroxaban Sales and Value (2013-2018)
8.1.1 India Rivaroxaban Sales and Growth Rate (2013-2018)
8.1.2 India Rivaroxaban Revenue and Growth Rate (2013-2018)
8.1.3 India Rivaroxaban Sales Price Trend (2013-2018)
8.2 India Rivaroxaban Sales Volume and Market Share by Players (2013-2018)
8.3 India Rivaroxaban Sales Volume and Market Share by Type (2013-2018)
8.4 India Rivaroxaban Sales Volume and Market Share by Application (2013-2018)

9 Global Rivaroxaban Players/Suppliers Profiles and Sales Data
9.1 Bayer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Rivaroxaban Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 J&J
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Rivaroxaban Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview

10 Rivaroxaban Maufacturing Cost Analysis
10.1 Rivaroxaban Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Rivaroxaban
10.3 Manufacturing Process Analysis of Rivaroxaban

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Rivaroxaban Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Rivaroxaban Market Forecast (2018-2025)
14.1 Global Rivaroxaban Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Rivaroxaban Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Rivaroxaban Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Rivaroxaban Price and Trend Forecast (2018-2025)
14.2 Global Rivaroxaban Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Rivaroxaban Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Rivaroxaban Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Rivaroxaban Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Rivaroxaban Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Rivaroxaban Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Rivaroxaban Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Rivaroxaban Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Rivaroxaban Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Rivaroxaban Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Rivaroxaban Sales Forecast by Type (2018-2025)
14.3.2 Global Rivaroxaban Revenue Forecast by Type (2018-2025)
14.3.3 Global Rivaroxaban Price Forecast by Type (2018-2025)
14.4 Global Rivaroxaban Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Rivaroxaban
Figure Global Rivaroxaban Sales Volume Comparison (M Units) by Type (2013-2025)
Figure Global Rivaroxaban Sales Volume Market Share by Type (Product Category) in 2017
Figure 2.5 mg Product Picture
Figure 10 mg Product Picture
Figure 15 mg Product Picture
Figure 20 mg Product Picture
Figure Global Rivaroxaban Sales Comparison (M Units) by Application (2013-2025)
Figure Global Sales Market Share of Rivaroxaban by Application in 2017
Figure Acute Coronary Syndrome (ACS) Examples
Table Key Downstream Customer in Acute Coronary Syndrome (ACS)
Figure Venous Thromboembolism (VTE) Examples
Table Key Downstream Customer in Venous Thromboembolism (VTE)
Figure Global Rivaroxaban Market Size (Million USD) by Regions (2013-2025)
Figure United States Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Rivaroxaban Sales Volume (M Units) and Growth Rate (2013-2025)
Figure Global Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Rivaroxaban Sales Volume (M Units) (2013-2018)
Table Global Rivaroxaban Sales (M Units) of Key Players/Suppliers (2013-2018)
Table Global Rivaroxaban Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Rivaroxaban Sales Share by Players/Suppliers
Figure 2017 Rivaroxaban Sales Share by Players/Suppliers
Figure Global Rivaroxaban Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Rivaroxaban Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Rivaroxaban Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Rivaroxaban Revenue Share by Players
Table 2017 Global Rivaroxaban Revenue Share by Players
Table Global Rivaroxaban Sales (M Units) and Market Share by Type (2013-2018)
Table Global Rivaroxaban Sales Share (M Units) by Type (2013-2018)
Figure Sales Market Share of Rivaroxaban by Type (2013-2018)
Figure Global Rivaroxaban Sales Growth Rate by Type (2013-2018)
Table Global Rivaroxaban Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Rivaroxaban Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Rivaroxaban by Type (2013-2018)
Figure Global Rivaroxaban Revenue Growth Rate by Type (2013-2018)
Table Global Rivaroxaban Sales Volume (M Units) and Market Share by Region (2013-2018)
Table Global Rivaroxaban Sales Share by Region (2013-2018)
Figure Sales Market Share of Rivaroxaban by Region (2013-2018)
Figure Global Rivaroxaban Sales Growth Rate by Region in 2017
Table Global Rivaroxaban Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Rivaroxaban Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Rivaroxaban by Region (2013-2018)
Figure Global Rivaroxaban Revenue Growth Rate by Region in 2017
Table Global Rivaroxaban Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Rivaroxaban Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Rivaroxaban by Region (2013-2018)
Figure Global Rivaroxaban Revenue Market Share by Region in 2017
Table Global Rivaroxaban Sales Volume (M Units) and Market Share by Application (2013-2018)
Table Global Rivaroxaban Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Rivaroxaban by Application (2013-2018)
Figure Global Rivaroxaban Sales Market Share by Application (2013-2018)
Figure United States Rivaroxaban Sales (M Units) and Growth Rate (2013-2018)
Figure United States Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Rivaroxaban Sales Price (USD/Unit) Trend (2013-2018)
Table United States Rivaroxaban Sales Volume (M Units) by Players (2013-2018)
Table United States Rivaroxaban Sales Volume Market Share by Players (2013-2018)
Figure United States Rivaroxaban Sales Volume Market Share by Players in 2017
Table United States Rivaroxaban Sales Volume (M Units) by Type (2013-2018)
Table United States Rivaroxaban Sales Volume Market Share by Type (2013-2018)
Figure United States Rivaroxaban Sales Volume Market Share by Type in 2017
Table United States Rivaroxaban Sales Volume (M Units) by Application (2013-2018)
Table United States Rivaroxaban Sales Volume Market Share by Application (2013-2018)
Figure United States Rivaroxaban Sales Volume Market Share by Application in 2017
Figure Europe Rivaroxaban Sales (M Units) and Growth Rate (2013-2018)
Figure Europe Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Rivaroxaban Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Rivaroxaban Sales Volume (M Units) by Players (2013-2018)
Table Europe Rivaroxaban Sales Volume Market Share by Players (2013-2018)
Figure Europe Rivaroxaban Sales Volume Market Share by Players in 2017
Table Europe Rivaroxaban Sales Volume (M Units) by Type (2013-2018)
Table Europe Rivaroxaban Sales Volume Market Share by Type (2013-2018)
Figure Europe Rivaroxaban Sales Volume Market Share by Type in 2017
Table Europe Rivaroxaban Sales Volume (M Units) by Application (2013-2018)
Table Europe Rivaroxaban Sales Volume Market Share by Application (2013-2018)
Figure Europe Rivaroxaban Sales Volume Market Share by Application in 2017
Figure China Rivaroxaban Sales (M Units) and Growth Rate (2013-2018)
Figure China Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Rivaroxaban Sales Price (USD/Unit) Trend (2013-2018)
Table China Rivaroxaban Sales Volume (M Units) by Players (2013-2018)
Table China Rivaroxaban Sales Volume Market Share by Players (2013-2018)
Figure China Rivaroxaban Sales Volume Market Share by Players in 2017
Table China Rivaroxaban Sales Volume (M Units) by Type (2013-2018)
Table China Rivaroxaban Sales Volume Market Share by Type (2013-2018)
Figure China Rivaroxaban Sales Volume Market Share by Type in 2017
Table China Rivaroxaban Sales Volume (M Units) by Application (2013-2018)
Table China Rivaroxaban Sales Volume Market Share by Application (2013-2018)
Figure China Rivaroxaban Sales Volume Market Share by Application in 2017
Figure Japan Rivaroxaban Sales (M Units) and Growth Rate (2013-2018)
Figure Japan Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Rivaroxaban Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Rivaroxaban Sales Volume (M Units) by Players (2013-2018)
Table Japan Rivaroxaban Sales Volume Market Share by Players (2013-2018)
Figure Japan Rivaroxaban Sales Volume Market Share by Players in 2017
Table Japan Rivaroxaban Sales Volume (M Units) by Type (2013-2018)
Table Japan Rivaroxaban Sales Volume Market Share by Type (2013-2018)
Figure Japan Rivaroxaban Sales Volume Market Share by Type in 2017
Table Japan Rivaroxaban Sales Volume (M Units) by Application (2013-2018)
Table Japan Rivaroxaban Sales Volume Market Share by Application (2013-2018)
Figure Japan Rivaroxaban Sales Volume Market Share by Application in 2017
Figure Southeast Asia Rivaroxaban Sales (M Units) and Growth Rate (2013-2018)
Figure Southeast Asia Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Rivaroxaban Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Rivaroxaban Sales Volume (M Units) by Players (2013-2018)
Table Southeast Asia Rivaroxaban Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Rivaroxaban Sales Volume Market Share by Players in 2017
Table Southeast Asia Rivaroxaban Sales Volume (M Units) by Type (2013-2018)
Table Southeast Asia Rivaroxaban Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Rivaroxaban Sales Volume Market Share by Type in 2017
Table Southeast Asia Rivaroxaban Sales Volume (M Units) by Application (2013-2018)
Table Southeast Asia Rivaroxaban Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Rivaroxaban Sales Volume Market Share by Application in 2017
Figure India Rivaroxaban Sales (M Units) and Growth Rate (2013-2018)
Figure India Rivaroxaban Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Rivaroxaban Sales Price (USD/Unit) Trend (2013-2018)
Table India Rivaroxaban Sales Volume (M Units) by Players (2013-2018)
Table India Rivaroxaban Sales Volume Market Share by Players (2013-2018)
Figure India Rivaroxaban Sales Volume Market Share by Players in 2017
Table India Rivaroxaban Sales Volume (M Units) by Type (2013-2018)
Table India Rivaroxaban Sales Volume Market Share by Type (2013-2018)
Figure India Rivaroxaban Sales Volume Market Share by Type in 2017
Table India Rivaroxaban Sales Volume (M Units) by Application (2013-2018)
Table India Rivaroxaban Sales Volume Market Share by Application (2013-2018)
Figure India Rivaroxaban Sales Volume Market Share by Application in 2017
Table Bayer Basic Information List
Table Bayer Rivaroxaban Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Rivaroxaban Sales Growth Rate (2013-2018)
Figure Bayer Rivaroxaban Sales Global Market Share (2013-2018)
Figure Bayer Rivaroxaban Revenue Global Market Share (2013-2018)
Table J&J Basic Information List
Table J&J Rivaroxaban Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure J&J Rivaroxaban Sales Growth Rate (2013-2018)
Figure J&J Rivaroxaban Sales Global Market Share (2013-2018)
Figure J&J Rivaroxaban Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivaroxaban
Figure Manufacturing Process Analysis of Rivaroxaban
Figure Rivaroxaban Industrial Chain Analysis
Table Raw Materials Sources of Rivaroxaban Major Players in 2017
Table Major Buyers of Rivaroxaban
Table Distributors/Traders List
Figure Global Rivaroxaban Sales Volume (M Units) and Growth Rate Forecast (2018-2025)
Figure Global Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Rivaroxaban Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Rivaroxaban Sales Volume (M Units) Forecast by Regions (2018-2025)
Figure Global Rivaroxaban Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Rivaroxaban Sales Volume Market Share Forecast by Regions in 2025
Table Global Rivaroxaban Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Rivaroxaban Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Rivaroxaban Revenue Market Share Forecast by Regions in 2025
Figure United States Rivaroxaban Sales Volume (M Units) and Growth Rate Forecast (2018-2025)
Figure United States Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Rivaroxaban Sales Volume (M Units) and Growth Rate Forecast (2018-2025)
Figure Europe Rivaroxaban Revenue and Growth Rate Forecast (2018-2025)
Figure China Rivaroxaban Sales Volume (M Units) and Growth Rate Forecast (2018-2025)
Figure China Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Rivaroxaban Sales Volume (M Units) and Growth Rate Forecast (2018-2025)
Figure Japan Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Rivaroxaban Sales Volume (M Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Rivaroxaban Sales Volume (M Units) and Growth Rate Forecast (2018-2025)
Figure India Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Rivaroxaban Sales (M Units) Forecast by Type (2018-2025)
Figure Global Rivaroxaban Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Rivaroxaban Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Rivaroxaban Revenue Market Share Forecast by Type (2018-2025)
Table Global Rivaroxaban Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Rivaroxaban Sales (M Units) Forecast by Application (2018-2025)
Figure Global Rivaroxaban Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のリヴァロクサバン市場2018(Global Rivaroxaban Sales Market Report 2018)]についてメールでお問い合わせはこちらでお願いします。